BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12395995)

  • 1. Botulinum toxin type B for treatment of spasmodic dysphonia: a case report.
    Sataloff RT; Heman-Ackah YD; Simpson LL; Park JB; Zwislewski A; Sokolow C; Mandel S
    J Voice; 2002 Sep; 16(3):422-4. PubMed ID: 12395995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to botulinum toxin injections for spasmodic dysphonia.
    Smith ME; Ford CN
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for the treatment of spasmodic dysphonia.
    Gibbs SR; Blitzer A
    Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human response to botulinum toxin injection: type B compared with type A.
    Sloop RR; Cole BA; Escutin RO
    Neurology; 1997 Jul; 49(1):189-94. PubMed ID: 9222189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dosage of botulinum toxin type B in adductor type spasmodic dysphonia].
    Schönweiler R; Zwirner P
    HNO; 2005 Feb; 53(2):166-73. PubMed ID: 15060715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice Patterns and Barriers in Botulinum Toxin Injection for the Treatment of Voice Disorders.
    McGarey PO; Simpson CB; Daniero JJ
    J Voice; 2022 Jan; 36(1):113-118. PubMed ID: 32467003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
    Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
    Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].
    Schwemmle C; Ptok M
    HNO; 2007 May; 55(5):399-402. PubMed ID: 17431567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
    Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
    Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injection for abductor spasmodic dysphonia under cervical ultrasonography guidance.
    Kunieda C; Nin F; Ohashi T; Hosokawa K; Watanabe Y; Ogawa T; Mori T; Kanazawa T
    Auris Nasus Larynx; 2024 Apr; 51(2):361-364. PubMed ID: 37838568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.
    Whurr R; Nye C; Lorch M
    Int J Lang Commun Disord; 1998; 33 Suppl():327-9. PubMed ID: 10343714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.
    Lees AJ; Turjanski N; Rivest J; Whurr R; Lorch M; Brookes G
    J Neurol; 1992 Jan; 239(1):1-4. PubMed ID: 1541963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.